Schuur A G, Legger F F, van Meeteren M E, Moonen M J, van Leeuwen-Bol I, Bergman A, Visser T J, Brouwer A
Toxicology Group, Department of Food Technology and Nutritional Sciences, Agricultural University Wageningen, 6700 EA Wageningen, The Netherlands.
Chem Res Toxicol. 1998 Sep;11(9):1075-81. doi: 10.1021/tx9800046.
Earlier studies in our laboratory showed that hydroxylated metabolites of polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), and dibenzofurans (PCDFs) competitively inhibit thyroxine (T4) binding to transthyretin (TTR) and type I deiodinase (D1) activity. In this study, we investigated the possible inhibitory effects of hydroxylated metabolites of polyhalogenated aromatic hydrocarbons (PHAHs) on iodothyronine sulfotransferase activity. Rat liver cytosol was used as a source of sulfotransferase enzyme in an in vitro assay with 125I-labeled 3,3'-diiodothyronine (T2) as a model substrate. Increasing amounts of hydroxylated PCBs, PCDDs, or PCDFs or extracts from incubation mixtures of PHAHs and induced liver microsomes were added as potential inhibitors of T2 sulfotransferase activity. Hydroxylated metabolites of PCBs, PCDDs, and PCDFs were found to be potent inhibitors of T2 sulfotransferase activity in vitro with IC50 values in the low micromolar range (0.2-3.8 microM). The most potent inhibitor of T2 sulfotransferase activity in our experiments was the PCB metabolite 3-hydroxy-2,3',4, 4',5-pentachlorobiphenyl with an IC50 value of 0.2 microM. A hydroxyl group in the para or meta position appeared to be an important structural requirement for T2 sulfotransferase inhibition by PCB metabolites. Ortho hydroxy PCBs were much less potent, and none of the parent PHAHs was capable of inhibiting T2 sulfotransferase activity. In addition, the formation of T2 sulfotransferase-inhibiting metabolites of individual brominated diphenyl ethers and nitrofen as well as from some commercial PHAH mixtures (e.g., Bromkal, Clophen A50, and Aroclor 1254) was also demonstrated. These results indicate that hydroxylated PHAHs are potent inhibitors of thyroid hormone sulfation. Since thyroid hormone sulfation may play an important role in regulating free hormone levels in the fetus, and PCB metabolites are known to accumulate in fetal tissues after maternal exposure to PCBs, these observations may have implications for fetal thyroid hormone homeostasis and development.
我们实验室早期的研究表明,多氯联苯(PCBs)、二苯并 - p - 二恶英(PCDDs)和二苯并呋喃(PCDFs)的羟基化代谢产物竞争性抑制甲状腺素(T4)与转甲状腺素蛋白(TTR)的结合以及Ⅰ型脱碘酶(D1)的活性。在本研究中,我们调查了多卤代芳烃(PHAHs)的羟基化代谢产物对碘甲状腺原氨酸硫酸转移酶活性可能的抑制作用。在以125I标记的3,3'-二碘甲状腺原氨酸(T2)作为模型底物的体外试验中,大鼠肝脏胞质溶胶被用作硫酸转移酶的来源。添加越来越多的羟基化PCBs、PCDDs或PCDFs,或者PHAHs与诱导的肝脏微粒体孵育混合物的提取物,作为T2硫酸转移酶活性的潜在抑制剂。发现PCBs、PCDDs和PCDFs的羟基化代谢产物在体外是T2硫酸转移酶活性的强效抑制剂,其半数抑制浓度(IC50)值在低微摩尔范围内(0.2 - 3.8微摩尔)。在我们的实验中,T2硫酸转移酶活性最有效的抑制剂是PCB代谢产物3 - 羟基 - 2,3',4,4',5 - 五氯联苯,IC50值为0.2微摩尔。对位或间位的羟基似乎是PCB代谢产物抑制T2硫酸转移酶的重要结构要求。邻位羟基化的PCBs效力要低得多,并且没有一种母体PHAHs能够抑制T2硫酸转移酶活性。此外,还证实了个别溴化二苯醚和除草醚以及一些商业PHAH混合物(如Bromkal、Clophen A50和Aroclor 1254)形成了抑制T2硫酸转移酶的代谢产物。这些结果表明,羟基化的PHAHs是甲状腺激素硫酸化的强效抑制剂。由于甲状腺激素硫酸化可能在调节胎儿游离激素水平中起重要作用,并且已知母体接触PCBs后PCB代谢产物会在胎儿组织中蓄积,这些观察结果可能对胎儿甲状腺激素稳态和发育有影响。